Lisha Du
Affiliated Zhongshan Hospital of Dalian University(CN)
Publications by Year
Research Areas
Tryptophan and brain disorders, Alzheimer's disease research and treatments, Gut microbiota and health, Stress Responses and Cortisol, Drug Transport and Resistance Mechanisms
Most-Cited Works
- → Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn–AhR–AQP4 signaling pathway(2020)140 cited
- → The IDO Inhibitor Coptisine Ameliorates Cognitive Impairment in a Mouse Model of Alzheimer's Disease(2014)100 cited
- → H2S suppresses indoleamine 2, 3-dioxygenase 1 and exhibits immunotherapeutic efficacy in murine hepatocellular carcinoma(2019)31 cited
- → Amyloid β neurotoxicity is IDO1–Kyn–AhR dependent and blocked by IDO1 inhibitor(2020)27 cited
- → Lingguizhugan decoction ameliorates cognitive impairment in AD-like mice by influencing the microbiome–gut–brain axis mediated by SCFAs(2024)25 cited
- → The relationship among amyloid-β deposition, sphingomyelin level, and the expression and function of P-glycoprotein in Alzheimer’s disease pathological process(2022)12 cited
- → Modulation of Intestinal Folate Absorption by Erythropoietinin Vitro(2013)11 cited
- → Gastrointestinal exposure to silica nanoparticles induced Alzheimer’s disease-like neurotoxicity in mice relying on gut microbiota and modulation through TLR4/NF-κB and HDAC(2025)8 cited
- → SMS regulates the expression and function of P-gp and MRP2 in Caco-2 cells(2016)5 cited
- → Correction: Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn–AhR–AQP4 signaling pathway(2021)5 cited